ArticleBMC cancer2024

Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy.

Shaoli Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.